NCT07481110|Recruiting
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
ECLIPSE-CG
Loading search results
ECLIPSE-CG
Sponsor study identifier
observational
1,000
1 country
15
Study Start
August 5, 2025
Actual (reported)Primary Completion
August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 5, 2025
Actual (reported)September 4, 2025
Actual (reported)March 18, 2026
Actual (reported)August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Demographic characteristics of patients with gastric cancer in Algeria
The patient's demographic profile will include age (years) and sex. Body Mass Index (BMI) will be calculated using weight (kg) and height (m) according to the formula BMI = weight / height² (kg/m²).
At Baseline ( Initial visit )
Sociological characteristics of patients with gastric cancer in Algeria
The patient's sociological profile will be described as a composite variable : Education level (primary, secondary, university, other), Profession (employed, unemployed, retired, student, other), Place of residence (current residence; urban or rural), Origin (wilaya of birth/origin)
At Baseline ( Initial visit )
Epidemiological characteristics of patients with gastric cancer in Algeria.
Patients with histologically confirmed gastric cancer, followed in the participating oncology departments.
Cac Blida
Algiers, Algeria, 16000, Algeria
CHU Béni Messous
Algiers, Algeria, 16000, Algeria
First Submitted
September 4, 2025
First Posted
March 18, 2026
Study Start
August 5, 2025
Actual (reported)Primary Completion
August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Frequency (%) of epidemiological risk factors including family history of cancer, Helicobacter pylori infection, smoking status, alcohol consumption, dietary habits, and exposure to chemical substances.
At Baseline (Initial Visit)
Clinical characteristics of patients with gastric cancer in Algeria.
Distribution of patients according to initial symptoms, tumor localization, histological characteristics, biomarker expression, presence of metastases, and tumor stage according to the AJCC classification.
At Basline ( Initial Visit)
Evolutionary characteristics of patients with gastric cancer.
Distribution of treatment modalities including surgery (palliative or curative) and chemotherapy (adjuvant or treatment lines), as well as treatment response, complications, disease-free survival (DFS), and duration of response.
At Baseline ( Initial Visit)
Diagnostic modalities in patients with gastric cancer in Algeria
At Basline (Initial Visit)
Therapeutic management modalities
At Baseline (Initial Visit)
Contact the study team to confirm eligibility.
CPMC
Algiers, Algeria
EPH Rouiba
Algiers, Algeria
CHU Annaba
Annaba, Algeria
CHU Constantine
Constantine, Algeria
EPH Constantine
Constantine, Algeria
CAC Oued Souf
El Oued, Algeria
CAC Oran
Oran, Algeria
CHU Oran
Oran, Algeria
EHU Oran
Oran, Algeria
CAC Sétif
Sétif, Algeria
CAC Sidi Bel Abbès
Sidi Bel Abbes, Algeria
EPH Sidi Ghiles
Tipasa, Algeria
CAC DBK
Tizi Ouzou, Algeria
Study Completion
August 5, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 27, 2026
Record last verified: 2025-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: